Cary J. Nolan is Director at TomoTherapy Inc (TOMO). They have made 5 open-market trades across 2 companies since 2007, most recently 2011-06-10.
CIK 0001397298
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TOMO | SELL | 2010-05-12 | 2010-05-12 | $3.70 | $56K | N/A | N/A | N/A |
| TOMO | SELL · 10b5-1 | 2010-04-28 | 2010-04-30 | $3.90 | $59K | N/A | N/A | N/A |
| TOMO | SELL | 2010-03-10 | 2010-03-11 | $3.22 | $100K | N/A | N/A | N/A |
| TOMO | SELL | 2010-02-24 | 2010-02-26 | $3.39 | $85K | N/A | N/A | N/A |
| TTPY | SELL | 2007-10-16 | 2007-10-18 | $22.25 | $1.9M | N/A | N/A | N/A |
| TTPY | SELL | 2007-05-14 | 2007-08-20 | $19.00 | $258K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.